Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

2013 ◽  
Vol 1 (4) ◽  
pp. 295-305 ◽  
Author(s):  
Agnès Hartemann ◽  
Gilbert Bensimon ◽  
Christine A Payan ◽  
Sophie Jacqueminet ◽  
Olivier Bourron ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Low Dose ◽  
Controlled Trial ◽  
Phase 1 ◽  
Interleukin 2 ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double‐blind, placebo‐controlled trial

2020 ◽  
Vol 8 (6) ◽  
pp. 695-704
Author(s):  
Anne‐Marie Langmach Wegeberg ◽  
Christian Stevns Hansen ◽  
Adam D Farmer ◽  
Jesper Scott Karmisholt ◽  
Asbjorn M Drewes ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Controlled Trial ◽  
Colonic Transit ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes

PLoS ONE ◽  
2015 ◽  
Vol 10 (9) ◽  
pp. e0137525 ◽  
Author(s):  
Benjamin Udoka Nwosu ◽  
Louise Maranda ◽  
Karen Cullen ◽  
Lisa Greenman ◽  
Jody Fleshman ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Metformin Therapy ◽  
Obese Youth

scholarly journals Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

The Lancet ◽  
2011 ◽  
Vol 378 (9789) ◽  
pp. 412-419 ◽  
Author(s):  
Tihamer Orban ◽  
Brian Bundy ◽  
Dorothy J Becker ◽  
Linda A DiMeglio ◽  
Stephen E Gitelman ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Recent Onset ◽  
Onset Type
Sign in / Sign up

Export Citation Format

Share Document